vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Stock Yards Bancorp, Inc. (SYBT). Click either name above to swap in a different company.

Stock Yards Bancorp, Inc. is the larger business by last-quarter revenue ($104.4M vs $75.5M, roughly 1.4× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 11.7%). Stock Yards Bancorp, Inc. produced more free cash flow last quarter ($154.0M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 11.9%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Community Trust Bancorp is an American regional bank holding company that was founded in 1903 as Pikeville National Bank. The renamed corporation continues to have its headquarters in Pikeville, Kentucky, at the heart of Appalachia. Community Trust Bancorp operates a commercial bank, Community Trust Bank, and a trust company, Community Trust and Investment Company of Lexington.

PBYI vs SYBT — Head-to-Head

Bigger by revenue
SYBT
SYBT
1.4× larger
SYBT
$104.4M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+16.1% gap
PBYI
27.7%
11.7%
SYBT
More free cash flow
SYBT
SYBT
$139.6M more FCF
SYBT
$154.0M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
11.9%
SYBT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
SYBT
SYBT
Revenue
$75.5M
$104.4M
Net Profit
$36.6M
Gross Margin
69.3%
Operating Margin
22.7%
45.9%
Net Margin
35.1%
Revenue YoY
27.7%
11.7%
Net Profit YoY
15.5%
EPS (diluted)
$0.26
$1.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
SYBT
SYBT
Q4 25
$75.5M
$104.4M
Q3 25
$54.5M
$101.5M
Q2 25
$52.4M
$97.8M
Q1 25
$46.0M
$93.5M
Q4 24
$59.1M
$93.5M
Q3 24
$80.5M
$89.8M
Q2 24
$47.1M
$85.7M
Q1 24
$43.8M
$83.3M
Net Profit
PBYI
PBYI
SYBT
SYBT
Q4 25
$36.6M
Q3 25
$8.8M
$36.2M
Q2 25
$5.9M
$34.0M
Q1 25
$3.0M
$33.3M
Q4 24
$31.7M
Q3 24
$20.3M
$29.4M
Q2 24
$-4.5M
$27.6M
Q1 24
$-4.8M
$25.9M
Gross Margin
PBYI
PBYI
SYBT
SYBT
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
PBYI
PBYI
SYBT
SYBT
Q4 25
22.7%
45.9%
Q3 25
17.6%
45.0%
Q2 25
12.7%
43.9%
Q1 25
8.7%
44.5%
Q4 24
22.6%
41.9%
Q3 24
27.4%
41.2%
Q2 24
-4.6%
41.2%
Q1 24
-5.3%
39.5%
Net Margin
PBYI
PBYI
SYBT
SYBT
Q4 25
35.1%
Q3 25
16.2%
35.7%
Q2 25
11.2%
34.8%
Q1 25
6.5%
35.6%
Q4 24
33.9%
Q3 24
25.2%
32.7%
Q2 24
-9.6%
32.2%
Q1 24
-11.0%
31.1%
EPS (diluted)
PBYI
PBYI
SYBT
SYBT
Q4 25
$0.26
$1.24
Q3 25
$0.17
$1.23
Q2 25
$0.12
$1.15
Q1 25
$0.06
$1.13
Q4 24
$0.40
$1.07
Q3 24
$0.41
$1.00
Q2 24
$-0.09
$0.94
Q1 24
$-0.10
$0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
SYBT
SYBT
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$22.7M
$26.8M
Stockholders' EquityBook value
$130.3M
$1.1B
Total Assets
$216.3M
$9.5B
Debt / EquityLower = less leverage
0.17×
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
SYBT
SYBT
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$93.2M
Q4 24
$101.0M
Q3 24
$96.7M
Q2 24
$96.8M
Q1 24
$107.2M
Total Debt
PBYI
PBYI
SYBT
SYBT
Q4 25
$22.7M
$26.8M
Q3 25
$34.0M
$26.8M
Q2 25
$45.3M
Q1 25
$56.7M
$26.8M
Q4 24
$68.0M
$26.8M
Q3 24
$79.3M
$26.8M
Q2 24
$90.7M
$26.8M
Q1 24
$102.0M
$26.8M
Stockholders' Equity
PBYI
PBYI
SYBT
SYBT
Q4 25
$130.3M
$1.1B
Q3 25
$115.3M
$1.0B
Q2 25
$104.7M
$1.0B
Q1 25
$97.1M
$975.5M
Q4 24
$92.1M
$940.5M
Q3 24
$71.1M
$934.1M
Q2 24
$48.5M
$894.5M
Q1 24
$51.0M
$874.7M
Total Assets
PBYI
PBYI
SYBT
SYBT
Q4 25
$216.3M
$9.5B
Q3 25
$202.9M
$9.3B
Q2 25
$194.9M
$9.2B
Q1 25
$196.2M
$9.0B
Q4 24
$213.3M
$8.9B
Q3 24
$220.7M
$8.4B
Q2 24
$205.0M
$8.3B
Q1 24
$214.1M
$8.1B
Debt / Equity
PBYI
PBYI
SYBT
SYBT
Q4 25
0.17×
0.02×
Q3 25
0.30×
0.03×
Q2 25
0.43×
Q1 25
0.58×
0.03×
Q4 24
0.74×
0.03×
Q3 24
1.12×
0.03×
Q2 24
1.87×
0.03×
Q1 24
2.00×
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
SYBT
SYBT
Operating Cash FlowLast quarter
$14.4M
$166.0M
Free Cash FlowOCF − Capex
$14.4M
$154.0M
FCF MarginFCF / Revenue
19.1%
147.5%
Capex IntensityCapex / Revenue
0.0%
11.5%
Cash ConversionOCF / Net Profit
4.54×
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$260.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
SYBT
SYBT
Q4 25
$14.4M
$166.0M
Q3 25
$9.7M
$38.2M
Q2 25
$14.1M
$55.9M
Q1 25
$3.6M
$19.8M
Q4 24
$15.6M
$142.9M
Q3 24
$11.0M
$55.4M
Q2 24
$1.0M
$51.1M
Q1 24
$11.2M
$17.4M
Free Cash Flow
PBYI
PBYI
SYBT
SYBT
Q4 25
$14.4M
$154.0M
Q3 25
$9.7M
$35.2M
Q2 25
$14.1M
$53.5M
Q1 25
$3.6M
$17.8M
Q4 24
$15.6M
$133.0M
Q3 24
$11.0M
$53.9M
Q2 24
$1.0M
$47.9M
Q1 24
$15.6M
FCF Margin
PBYI
PBYI
SYBT
SYBT
Q4 25
19.1%
147.5%
Q3 25
17.7%
34.6%
Q2 25
26.8%
54.7%
Q1 25
7.7%
19.1%
Q4 24
26.4%
142.3%
Q3 24
13.7%
60.0%
Q2 24
2.1%
55.9%
Q1 24
18.7%
Capex Intensity
PBYI
PBYI
SYBT
SYBT
Q4 25
0.0%
11.5%
Q3 25
0.0%
3.0%
Q2 25
0.0%
2.5%
Q1 25
0.1%
2.1%
Q4 24
0.0%
10.5%
Q3 24
0.0%
1.7%
Q2 24
0.0%
3.8%
Q1 24
0.0%
2.2%
Cash Conversion
PBYI
PBYI
SYBT
SYBT
Q4 25
4.54×
Q3 25
1.10×
1.05×
Q2 25
2.41×
1.64×
Q1 25
1.21×
0.59×
Q4 24
4.51×
Q3 24
0.54×
1.89×
Q2 24
1.85×
Q1 24
0.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons